Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Nob Hill Therapeutics
start up
United States
- Albuquerque, New Mexico
- 07/08/2024
- Series A
- $3,000,000
Nob Hill Therapeutics mission is to commercialize the first-of-its-kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.
- Industry Biotechnology Research
- Website https://nobhilltherapeutics.com/
- LinkedIn https://www.linkedin.com/company/nob-hill-therapeutics/
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)